This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Kline, Justin P.
Item Type | Name |
Concept
|
Mice, Transgenic
|
Concept
|
Mice, Inbred BALB C
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Models, Animal
|
Concept
|
Mice, Knockout
|
Concept
|
Mice
|
Concept
|
Hematologic Neoplasms
|
Concept
|
Disease Models, Animal
|
Concept
|
Mice, SCID
|
Concept
|
Mice, Inbred NOD
|
Academic Article
|
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
|
Academic Article
|
Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection.
|
Academic Article
|
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
|
Academic Article
|
Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma.
|
Academic Article
|
Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation.
|
Academic Article
|
Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.
|
Academic Article
|
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells.
|
Academic Article
|
Cellular and molecular requirements for rejection of B16 melanoma in the setting of regulatory T cell depletion and homeostatic proliferation.
|
Academic Article
|
PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model.
|
Academic Article
|
CD40 ligation reverses T cell tolerance in acute myeloid leukemia.
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
Academic Article
|
Therapeutic activity of high-dose intratumoral IFN-ß requires direct effect on the tumor vasculature.
|
Academic Article
|
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.
|
Academic Article
|
PD-1 regulates extrathymic regulatory T-cell differentiation.
|
Academic Article
|
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.
|
Academic Article
|
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
|
Academic Article
|
Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells.
|
Academic Article
|
STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia.
|
Academic Article
|
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.
|
Academic Article
|
Calreticulin promotes immunity and type I interferon-dependent survival in mice with acute myeloid leukemia.
|
Grant
|
Characterization of a T cell dysfunctional state induced in mice with AML
|
Academic Article
|
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
|
- Mouse
- models
- Hematologic Malignancies